How Experts Are Reacting to Trump’s Women’s Health Executive Order
Women’s health experts had mixed reactions to the Trump administration's executive order on women's health.
Trump Administration Announces $90 Payments to Help Cover Medicare Part B Premiums
The Trump administration is issuing one-time $90 payments to more than 20 million Medicare beneficiaries to help cover Part B premiums, though the payments may do little to offset rising healthcare costs.
presented by
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
Trump’s $500 ACA Refunds: ‘We Shouldn’t Confuse a Check With a Healthcare Affordability Strategy’
Trump’s $500 ACA refunds offer immediate financial relief to some enrollees, but healthcare experts question whether they address the broader affordability challenges facing Americans.
Providers Sound Alarm After RFK Jr. Fires Top USPSTF Leaders
Healthcare providers and researchers are warning that HHS Secretary Robert F. Kennedy Jr.’s firing of two USPSTF vice chairs could politicize one of the nation’s most influential preventive care panels.
How Healthcare Leaders are Reacting to the White House’s Proposed Fertility Benefit Rule
Healthcare leaders are divided over the Trump administration’s proposed rule to expand employer-sponsored fertility benefits, with some praising broader access and others saying it falls short of guaranteeing comprehensive coverage.
‘A Significant Assault on Our Health’: Healthcare Policy Leaders Condemn Trump’s Budget Proposal
President Donald Trump’s 2027 budget proposes deep healthcare cuts, raising concerns about harm to patients and research.
presented by
Automation Didn’t Dehumanize Care. Bad Systems Did.
We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.
Why Trump’s ‘Cash for Healthcare’ Idea Likely Wouldn’t Work in Practice
Last week, Trump proposed cutting out insurers and giving Americans cash to buy their own healthcare, claiming it would lower costs. Ali Diab, an economist and CEO of Collective Health, said the plan overlooks the real problem: concentrated payer power, opaque pricing and the financial risk people face without insurance.
How Healthcare Leaders Responded to Trump’s State of the Union
Some healthcare experts supported Trump’s comments on lowering prescription drug costs, while others criticized his remarks on health coverage.
Reclassifying Nursing Degrees Puts Us All At Risk
The decision to eliminate nursing and PA degrees from ‘professional degree’ status isn’t just a financial policy choice; it’s a workforce policy choice. And, unfortunately, it’s moving in the wrong direction at the worst possible time.
The OBBBA Is Creating Uncertainty and Disruption: What Health Plans Need to Know
Health plans are being asked to adapt quickly, to reconfigure technology, reimagine operations, and anticipate ripple effects that stretch across claims, member engagement, compliance, and workforce strategy.
presented by
The Healthcare Payments Industry Faces a Perception Challenge
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
We’re Running Out of Healthcare Workers. A Rose Gold Immigration Card Can Help.
Americans suffer when hospitals close, nursing homes fall below care standards and mental health services become inaccessible. Immigration should be part of the solution.
President Trump Can Act Now To Make Healthcare Affordable
The Trump administration can immediately take these two price transparency administrative actions to reduce costs and improve affordability.
How Hospitals Can Blunt the Effects of Tariffs
Artificial intelligence (AI) and advanced analytics can assist hospitals as they endure the uncertainty caused by tariffs.
Could Trump do for Branded Expensive Drugs What He Just Did for GLP-1s?
The Trump administration’s new deal lowers prices and expands access to GLP-1 drugs, but experts argue far broader reforms are needed to address high prescription drug costs overall.
Why Elderly Americans Are Bearing the Brunt of the Government Shutdown’s Impact
Time is of the essence, particularly for those with cognitive conditions. The loss of telehealth flexibilities, combined with disruptions to Medicaid, could have devastating consequences for millions of patients with dementia and other cognitive and behavioral conditions.